Glaukos (GKOS) Insiders Make Significant Share Sales

Tuesday, March 06, 2018 10:15 PM ET

Glaukos (GKOS) Insiders Make Significant Share Sales

SEC filings today revealed notable insider sales of Glaukos shares as two insiders — OrbiMed Advisors Llc, Director, and Jonathan Silverstein, Director — sold 1,673,000 shares in the company having a market value of approximately $53,574,383. These are the first insider buy/sell trades in the past 90 days. Adding the most recent activity to this 90-day history indicates insider trades have averaged 836,500 shares per transaction.

Insider buy/sell trading at Glaukos is greater than the 17 peer company average over the last 90-day period. The Medical Devices & Implants peer group saw 11 buy/sell trades during this period for an average of 0.6 transactions per company. The number of shares per buy/sell trade for Glaukos insiders was also higher. Within the peer group there were 0 shares purchased and 31,870 shares sold with company insiders selling 2,897 shares on average.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to compose and write this story.

Today’s Insider Activity
* OrbiMed Advisors Llc, Director, sold 836,500 shares
* Jonathan Silverstein, Director, sold 836,500 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.